University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 34 of 35
Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus
NCT00187447
Protecting the 'Hood Against Tobacco
NCT00187603
Flushes and Sertraline Trial
NCT00283192
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
NCT01519141
Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes
NCT00792532
Bupropion for Hospital-Based Smoking Cessation
NCT00261170
Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects
NCT00187681
Pager-Assisted Smoking Cessation Treatment
NCT01207310
Oral Contraceptive Pills Compared to Vaginal Rings
NCT00357526
Investigating Mucinase Activity in Airway Disease
NCT00596232
Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer
NCT00402285
Prevention Management Model for Early Childhood Caries (MAYA Project)
NCT00066950
Postoperative Pain Control With Fentanyl Patch in Patients Undergoing Mastectomy and TRAM or DIEP Flap Reconstruction
NCT01258296
A Randomized, Placebo-controlled, Double-blind Clinical Trial of Curcuminoids in Oral Lichen Planus
NCT00226174
Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area
NCT00702104
Neurotrophic Factors and Depression
NCT00812994
Multicenter Bone and Joint Health Study
NCT03033238
Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer
NCT00301860
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT
NCT00516152
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
NCT00304018
Fluoride Varnish Randomized Clinical Trial
NCT00066963
Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma
NCT00187499
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies
NCT00514722
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
NCT00071656
LGBT Internet Based Smoking Treatment - 1
NCT00111501
Study of Ductal Lavage in Women at High Risk for Breast Cancer
NCT00429988
Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected
NCT00218699
Genetic Basis for Variation in the Renal Elimination of Metformin
NCT00187720
Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
NCT00221312
Questioning Patients About Adverse Medical Events
NCT00187616
Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
NCT00290745
Effect of Dietary Protein Source on Calcium Metabolism
NCT00187538
Evolution of Pain From Herpes Zoster
NCT00305357
Study of Blood and Cheek Cell Samples From Patients With Glioma
NCT01009307
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
NCT00513175
Maintaining Nonsmoking: Older Smokers - 1
NCT00086385
Impact of Genetics on Metformin Pharmacokinetics
NCT00187798
Herbal Therapy in Treating Women With Metastatic Breast Cancer
NCT00028977
Novel Method to Diagnose Acute Myocardial Ischemia
NCT00285922
Treating Chinese Smokers With Interactive Expert System
NCT00713895
Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
NCT00581763
Evaluation of a Decision Assisting Tool for Prenatal Testing
NCT00686062
Evolution of Analgesic Tolerance With Opioids
NCT00275249
Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
NCT00023621
Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer
NCT00028964
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
NCT00305708
Home Care Management of Pediatric Pain
NCT00251628
Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance
NCT00187551
Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma
NCT00606242
Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus
NCT00582465
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.